We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New RNAi Treatment Targets Eye Inflammation

News   Feb 15, 2017 | Original story from Hokkaido University

 
New RNAi Treatment Targets Eye Inflammation

The newly developed RNAi agent suppressed chronic inflammation in the retinas of diabetic mice. The number of leukocytes (arrows) in the inflamed vasculature was significantly reduced in the RNAi-treated retina (right) comparing to the control experiment (left). Credit: Hokkaido University

 
 
 

RELATED ARTICLES

Cartilage Ear 3D-printed Without Scaffolding

News

A new approach to bioprinting has been demonstrated in a study that successfully 3D-printed biological tissues without scaffolds using "ink" made up of only stem cells.

READ MORE

Chemists’ Success in Synthesis Drives Development of Anti-cancer Agent

News

Researchers have now synthesized sufficient quantities of E7130, a drug candidate from the halichondrin class, to enable for the first time rigorous studies of its biological activity, pharmacological properties, and efficacy.

READ MORE

Cargo Trafficked Across Bacteria on "Treadmills"

News

Bacteria have more in common with human cells than first thought; cargo is transited along treadmill-like structures by viruses in a process similar to what is found in our own cells. Understanding the process is fundamental to developing tailor-made phages for resistant infections.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE